Huntington’s Disease

Karl Kieburtz, M.D.
Professor of Neurology, Community and Preventive Medicine, and Environmental Medicine; Senior Associate Dean, Clinical Research; Director, Clinical & Translational Science Institute, University of Rochester School of Medicine

C. Warren Olanow, M.D.
Professor of Neurology, and Neuroscience, Mount Sinai School of Medicine, New York

Ray Dorsey, M.D.
Professor of Neurology; Co-director, Center for Human Experimental Therapeutics (CHET), University of Rochester School of Medicine; Chair and President of the Huntingtonís Study Group

Andrew Feigin, M.D.
Professor of Neurology and Molecular Medicine; Director, Laboratory of Experimental Therapeutics for Movement Disorders, The Feinstein Institute for Medical Research; Director, Huntingtonís Disease Society of America Center of Excellence, Hofstra North Shore-LIJ School of Medicine

 

Multiple Sclerosis

Laura J. Balcer, M.D., M.S.C.E.
Professor of Neurology, New York University School of Medicine

Peter A. Calabresi, M.D.
Professor of Neurology, Johns Hopkins School of Medicine

Jeffrey A. Cohen, M.D.
Professor of Medicine, Cleveland Clinic Lerner College of Medicine ñ Mellen Center

Steven L. Galetta, M.D.
Professor and Chair of the Department of Neurology , New York University School of Medicine

Andrew D. Goodman, M.D.
Professor of Neurology, Chief of the Neuroimmunology Unit & Director of the Rochester Multiple Sclerosis Center, University of Rochester School of Medicine and Dentistry

Matilde Inglese, M.D., Ph.D.
Associate Professor of Neurology, Radiology & Neuroscience, Mount Sinai School of Medicine

Daniel Pelletier, M.D.
Professor of Neurology & Diagnostic Radiology, Chief, Multiple Sclerosis Center and Neuro-Immunology Division, Director, Yale Clinical Neuroscience Imaging Center (CNIC), Yale University School of Medicine